L2HGDH and nonpapillary renal cell carcinoma: Loss of L2HGDH in ccRCC leads to the accumulation of L2HG—an oncometabolite that inhibits the Ten-Eleven-Translocation enzymes, resulting in an adverse loss of hydroxymethylcytosine and gain of methylcytosine.